Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins. (Q44936401)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

title

Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Bianca Brandon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

Steve M Gentleman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

David T Dexter

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

14 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

issue

Pt 7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

2077-2097

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771339 AND SRC:MED&resulttype=core&format=json

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Use of antihypertensives and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Poor and protracted myelination as a contributory factor to neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Knockdown of L calcium channel subtypes: differential effects in neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Autogenous oscillatory potentials in neurons of the guinea pig substantia nigra pars compacta in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

alpha-Synuclein modulation of Ca2 signaling in human neuroblastoma (SH-SY5Y) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Calcium signaling in dendritic spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Dorsal motor nucleus of the vagus nerve: a cyto- and chemoarchitectonic study in the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Voltage-gated calcium channels and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Increased volume of the pigmented neurons in the locus coeruleus of schizophrenic subjects: a stereological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Dihydropyridine calcium channel blockers and the progression of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Use of calcium channel blockers and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Design-based stereology in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Antagonizing L-type Ca2 channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

The origins of oxidant stress in Parkinson's disease and therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Physiological phenotype and vulnerability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Parkinson's Disease-associated α-Synuclein Is a Calmodulin Substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134

Calbindin-1association and Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWT134